Banka BioLoo (NSE:BANKA) Marketable Securities: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BANKA Banka BioLoo Ltd NSE:BANKA
78 GF Score
Price ₹79.96
GF Value ₹96.49
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Banka BioLoo Marketable Securities?

Banka BioLoo NSE:BANKA +3.58% 78 Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:BANKA with a GF Score™ of 78/100 and a GF Value™ of ₹96.49 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Banka BioLoo's Marketable Securities for the quarter that ended in Jun. 2026 was ₹ Mil.

Banka BioLoo's annual Marketable Securities increased from Mar. 2024 (₹13.8 Mil) to Mar. 2025 (₹38.2 Mil) but then declined from Mar. 2025 (₹38.2 Mil) to Mar. 2026 (₹2.6 Mil).

Banka BioLoo  (NSE:BANKA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Banka BioLoo Marketable Securities Related Terms

Banka BioLoo Marketable Securities Historical Data

* Premium members only.

The historical data trend for Banka BioLoo's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Banka BioLoo Marketable Securities Chart

Banka BioLoo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.61 17.45 13.78 38.25 2.59

Banka BioLoo Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.00 - 2.59 -
NSE:BANKA
78GF Score
Banka BioLoo Ltd NSE:BANKA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Banka BioLoo Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹ Mil mean?
Banka BioLoo (NSE:BANKA) has a Marketable Securities of ₹ Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Banka BioLoo and its competitors.
Is Banka BioLoo's Marketable Securities too high?
Banka BioLoo's current Marketable Securities is ₹ Mil. Overall, Banka BioLoo has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Banka BioLoo's Marketable Securities compare to VLTO and ZWS?
Banka BioLoo's Marketable Securities of ₹ Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for an Industrial Products company?
A good Marketable Securities depends on the Industrial Products industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Banka BioLoo and its competitors. Banka BioLoo's current Marketable Securities is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Banka BioLoo stock overvalued right now?
Based on GuruFocus' analysis, Banka BioLoo (NSE:BANKA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹96.49, compared to a current price of ₹79.96 — trading 17.1% below its estimated fair value. The current Marketable Securities is ₹ Mil. Banka BioLoo's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Banka BioLoo (NSE:BANKA), the current Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Banka BioLoo (NSE:BANKA) Overvalued in 2026?

Based on GuruFocus' analysis, Banka BioLoo stock appears to be undervalued. The current stock price of ₹79.96 is trading 17.1% below its estimated GF Value™ of ₹96.49. GuruFocus considers Banka BioLoo to be Modestly Undervalued.

Key valuation signals for NSE:BANKA:

  • Marketable Securities: ₹ Mil
  • GF Value™: ₹96.49 vs. price of ₹79.96 (17.1% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the NSE:BANKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Banka BioLoo Business Description

Address 1405, Uma Nagar, 5th Floor, Prestige Phoenix, Begumpet, Hyderabad, TG, IND, 500016
Banka BioLoo Ltd provides sanitation infrastructures and human waste management solutions and services. It is engaged in the business of manufacturing, supplying, and installing Bio toilets, setting up Fecal Sludge Treatment Plants (FSTPs), waste water treatment plants, Effluent treatment plants, and their operation and maintenance. The company has only one reportable business segment, which is the manufacturing, supplying, and installation of Bio toilets and related AMOC services. It provides services to various schools, villages, resorts, indian railways, small communities, industrial factories, construction sites, and others. Geographically, the company operates only in India.
78GF Score

Get the complete analysis for NSE:BANKA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹79.96
Price
₹96.49
GF Value